Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
21.07.2026
A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously unknown mechanism of action for a synthetic peptide that mitigates excessive inflammatory responses in allergic asthma. This mechanism specifically inhibits a key inflammatory switch in the immune system and opens up new avenues for treating chronic inflammatory diseases. The findings have now been published in the journal Advanced Science.
21.07.2026
An international research team led by scientists from the Research Center Borstel has published the first comprehensive systematic review and meta-analysis examining the risk of tuberculosis (TB) among migrant children and adolescents arriving in Europe.
20.07.2026
Prof. Dr. Amelia Barber has accepted the call to the W3 professorship for “Functional Microbiome Research in Chronic Lung Diseases” and since July 2026 is establishing a new research group at the Research Center Borstel, Leibniz Lung Center (FZB). With her expertise in fungal and microbiome research, she expands the scientific profile of FZB and builds a bridge between infection and chronic lung disease research.